Endogenous cannabinoid receptor agonist anandamide induces peripheral antinociception by activation of ATP-sensitive K+ channels

Life Sciences

Volumn 88, Issue 15-16, 2011, Pages 653-657

  Reis, Gláucia Maria Lopes ^a   Ramos, Marina Abadia ^a   Pacheco, Daniela Da Fonseca ^a   Klein, André ^a   Perez, Andréa Castro ^a   Duarte, Igor Dimitri Gama ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Anandamide; Cannabinoids; Glibenclamide; K+ channel; Peripheral antinociception

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ANANDAMIDE; CARRAGEENAN; DEQUALINIUM; GLIBENCLAMIDE; PAXILLINE; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; HINDLIMB; HYPERALGESIA; INJECTION SITE; JOINT FUNCTION; MALE; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PAIN THRESHOLD; PRESSURE; RAT;

ANALGESICS; ANIMALS; ARACHIDONIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCANNABINOIDS; HYPERALGESIA; KATP CHANNELS; MALE; POLYUNSATURATED ALKAMIDES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1;

RATTUS;

EID: 79953276634     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.01.017     Document Type: Article

References (44)

1. Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, et al. Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 2007;10:870-9. (Pubitemid 47013432)
2. Ahluwalia J, Urban L, Capogna M, Bevan S, Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 2000;100:685-8.
3. Alexander S, Peters J, Mathie A, Mackenzie G, Smith A. Nomenclature supplement. Trends Pharmacol Sci, 12th Ed. 2001. p. 118-25.
4. Blednov YA, Stoffel M, Alva H, Harris RA. A pervasive mechanism for analgesia: activation of GIRK2 channel. Proc Natl Acad Sci USA 2003;100:277-82. (Pubitemid 36078065)
5. Bridges D, Rice A, Egertova M, Elphick MR, Winter J, Michael GJ. Localization of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridization and immunohistochemistry. Neuroscience 2003;119:803-12. (Pubitemid 36694807)
6. Calignano A, La Rana G, Giuffrida A, Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 1998;394:277-81. (Pubitemid 28335039)
7. + channels in hepatocytes and of nicotine responses in skeletal muscle. Eur J Pharmacol 1993;236:210-7.
8. 1 receptor antagonist, SR141716A, selectively facilitates nociceptive responses of dorsal horn neurones in the rat. Br J Pharmacol 1999;127:1765-7.
9. Cheng Y, Hitchcock SA. Targeting cannabinoid agonists for inflammatory and neuropathic pain. Expert Opin Investig Drugs 2007;16:951-65. (Pubitemid 47074154)
10. Devane WA, Hanus L, Breuer A, Pertwee RG, Steevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258:1946-9. (Pubitemid 23026736)
11. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994;372:686-91.
12. Dunn M. Dequalinium, a selective blocker of the slow afterhyperpolarization in rat sympathetic neurones in culture. Eur J Pharmacol 1994;252:189-94.
13. Edwards G, Weston AH. The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 1993;33:597-637. (Pubitemid 23116020)
14. Felder CC, Glass M. Cannabinoid receptors and their endogenous agonists. Annu Rev Pharmacol Toxicol 1998;38:179-200. (Pubitemid 28231493)
15. Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, et al. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. Fed Eur Biochem Soc J 1996;393:231-5. (Pubitemid 26298102)
16. Guindon J, Beaulieu P. Antihyperalgesic effects of local injections anandamide, ibuprofen, rofecoxib and their combinations in a model of neuropathic pain. Neuropharmacology 2006;50:814-23.
17. Guindon J, De Léan A, Beaulieu P. Local interactions between anandamide, an endocannabinoid, and ibuprofen, a nonsteroidal anti-inflammatory drug, in acute and inflammatory pain. Pain 2006;121:85-93. (Pubitemid 43261635)
18. 2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis. Br J Pharmacol 2007;150:153-63.
19. Hillard CJ. Biochemistry and pharmacology of the endocannabinoids arachidonylethanolamide and 2-arachidonylglycerol. Prostaglandins Other Lipid Mediat 2000;61:3-18. (Pubitemid 30216485)
20. Hohmann AG, Herkenham M. Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience 1999a;92:1171-5. (Pubitemid 29292557)
21. 1 receptormessenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study. Neuroscience 1999b;90:923-31.
22. Houser SJ, Eads M, Embrey JP, Welsh SP. Dynorphin B and spinal analgesia: induction of antinociception by cannabinoids CP55,940, delta 9-THC and anandamide. Brain Res 2000;857:337-42.
23. Ibrahim MM, Porreca F, Lai J, Albrecht PJ, Rice FL, Khodorova A, et al. CB2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids. Proc Natl Acad Sci USA 2005;102:3093-8. (Pubitemid 40299921)
24. Khasabova IA, Khasabov SG, Harding-Rose C, Coicou LG, Seybold BA, Lindberg AE, et al. A decrease in anandamide signalling contributes to the maintenance of cutaneous mechanical hyperalgesia in a model of bone cancer pain. J Neurosci 2008;28:11141-52.
25. Mason Jr DJ, Lowe J, Welch SP. Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception. Eur J Pharmacol 1999;378:237-48. (Pubitemid 29392924)
26. Ocaña M, Cendán CM, Cobos EJ, Entrena JM, Baeyens JM. Potassium channels and pain: present realities and future opportunities. Eur J Pharmacol 2004;500:203-19.
27. + channels. Eur J Pharmacol 2005;512:23-8.
28. 1 receptor. J Mol Signaling 2008;3:5.
29. Pertwee RG. Cannabinoid receptors and pain. Prog Neurobiol 2001;63:569-611. (Pubitemid 32115433)
30. Pertwee RG, Ross RA. Cannabinoid receptors and their ligands. Prostaglandins Leukot Essent Fatty Acids 2002;66:101-21. (Pubitemid 34743589)
31. Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissues. Arch Int Pharmacodyn Thér 1957;111:409-19.
32. Reis GML, Duarte IDG. Baclofen, an agonist at peripheral GABAB receptors, induces antinociception via activation of TEA sensitive potassium channels. Br J Pharmacol 2006;149:733-9. (Pubitemid 44748065)
33. Reis GML, Pacheco DF, Perez AC, Klein A, Ramos MA, Duarte IDG. Opioid receptor and NO/cGMP pathway as a mechanism of peripheral antinociceptive action of the cannabinoid receptor agonist anandamide. Life Sci 2009;85:351-6.
34. Rice AS. Cannabinoids and pain. Curr Opin Investig Drugs 2000;2:399-414. (Pubitemid 32279786)
35. Rice AS, Farquhar-Smith WP, Nagy I. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids 2002;66:243-56. (Pubitemid 34743599)
36. Richardson JD. Cannabinoids modulate pain by multiple mechanisms of action. J Pain 2000;1:2-14. (Pubitemid 30623460)
37. 1 receptors. Pain 1998;75:111-9.
38. + channels. Br J Pharmacol 2000;129:110-4.
39. 2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Eur J Neurosci 2005;22:371-9.
40. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev 2003;55:1-20. (Pubitemid 36268396)
41. Strangman NM, Patrick SL, Hohmann AG, Tsou K, Walker JM. Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res 1998;813:323-8. (Pubitemid 29009648)
42. Welch SP, Eads M. Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res 1999;848:183-90. (Pubitemid 30001667)
43. Welch SP, Dunlow LD, Patrick GS, Razdan RK. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to Δ9-THC after intrathecal administration to mice: blockade of D9-THC-induced antinociception. J Pharmacol Exp Ther 1995a;273:1235-44.
44. Welch SP, Thomas C, Patrick GS. Modulation of cannabinoid induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine. J Pharmacol Exp Ther 1995b;272:310-21.